| RGAVX | VCRAX | RGAVX / VCRAX | |
| Total Expense Ratio | 1.31 | 1.24 | 106% |
| Annual Report Gross Expense Ratio | 1.41 | 1.24 | 114% |
| Fund Existence | 10 years | 13 years | - |
| Gain YTD | 10.907 | 8.399 | 130% |
| Front Load | 6% | 6% | 100% |
| Min. Initial Investment | 1000 | 15000 | 7% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 172M | 1.71B | 10% |
| Annual Yield % from dividends | 2.93 | 1.39 | 212% |
| Returns for 1 year | 16.14 | 9.79 | 165% |
| Returns for 3 years | 53.26 | 44.43 | 120% |
| Returns for 5 years | 41.22 | 32.23 | 128% |
| Returns for 10 years | 106.59 | 64.05 | 166% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FISGX | 44.85 | 0.39 | +0.88% |
| Nuveen Small/Mid Cap Growth Opp I | |||
| PHSZX | 53.79 | 0.40 | +0.75% |
| PGIM Jennison Health Sciences Z | |||
| XLSR | 66.05 | 0.27 | +0.42% |
| State Street® US Sector Rotation ETF | |||
| ACCLX | 16.74 | 0.07 | +0.42% |
| American Century Mid Cap Value C | |||
| VVSGX | 20.42 | N/A | N/A |
| VALIC Company I Small Cap Growth | |||